Immunohistochemical expression of matrix metalloproteinase-2 and -9 in melanocytic nevi is altered by ultraviolet B

Photodermatology Photoimmunology and Photomedicine

Volumn 23, Issue 6, 2007, Pages 250-254

  Bakos, Renato Marchiori ^a   Bakos, Lucio ^a   Albano Edelweiss, Maria Isabel ^a   Cartell, André ^a   Mariante, José Carlos ^a   Soles Masiero, Nathália Costaguta Matas ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Gelatinase A; Gelatinase B; Nevi and melanomas; Photobiology; Ultraviolet rays

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; CANCER RISK; CANCER SURGERY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; MELANOCYTE; MELANOCYTIC NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIATION EXPOSURE; RISK ASSESSMENT; RISK FACTOR; ULTRAVIOLET B RADIATION;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEVUS, PIGMENTED; SKIN; ULTRAVIOLET RAYS;

EID: 35848967316     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2007.00322.x     Document Type: Article

References (24)

1. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.
2. Tronnier M, Smolle J, Wolff HH. Ultraviolet irradiation induces acute changes in melanocytic nevi. J Invest Dermatol 1995; 104: 475-478.
3. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-21494.
4. Fisher GJ, Wang Z, Datta SC, et al. Pathophisiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997; 337: 1419-1428.
5. Hofmann UB, Westphal JR, Van Muijen GN, et al. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000; 115: 337-344.
6. Vaisanen A, Tuominen H, Kallioinen M, et al. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 1996; 180: 283-289.
7. Simonetti O, Lucarini G, Brancorsini D, et al. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Cancer 2002; 95: 1963-1970.
8. Van Den Oord JJ, Paemen L, Opdednakker G, et al. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 1997; 151: 665-670.
9. Koivukangas V, Kallioinen M, Autio-Harmainen H, et al. UV irradiation induces the expression of gelatinases in human skin in vivo. Acta Derm Venereol 1994; 74: 279-282.
10. Krengel S, Alexander M, Brinckmann J, et al. MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light. J Cutan Pathol 2002; 29: 390-396.
11. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981; 75: 816-821.
12. Fisher GJ, Datta SC, Talwar HS, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379: 335-339.
13. Kobayashi T, Hattori S, Shinkai H. Matrix metalloproteinases-2 and -9 are secreted from human fibroblasts. Acta Derm Venereol 2003; 83: 105-107.
14. Kobayashi T, Hattori S, Nagai Y, et al. Secretion of different types of gelatinases from cultured human keratinocytes. J Dermatol 1997; 24: 213-216.
15. Bizik J, Bessou S, Felnerova D, et al. The proteolytic potential of normal human melanocytes: Comparison with other skin cells and melanoma cell lines. Pigment Cell Res 1996; 9: 255-264.
16. Wu CS, Yu CL, Wu CS, et al. Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes. Exp Dermatol 2004; 13: 755-763.
17. Jackson CJ, Nguyen M. Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol 1997; 29: 1167-1177.
18. Kut C, Hornebeck W, Groult N, et al. Influence of successive and combined ultraviolet A and B irradiations on matrix metalloelastases produced by human dermal fibroblasts in culture. Cell Biol Int 1997; 21: 347-352.
19. Ohnishi Y, Tajima S, Akiyama M, et al. Expression of elastin-related proteins and matrix metalloproteinases in actinic elastosis of sun-damaged skin. Arch Dermatol Res 2000; 292: 27-31.
20. Kossodo S, Wong WR, Simon G, et al. Effects of UVR and UVR-induced cytokines on production of extracellular matrix proteins and proteases by dermal fibroblasts cultured in collagen gels%. Photochem Photobiol 2004; 79: 86-93.
21. Kobayashi T, Onoda N, Takagi T, et al. Immunolocalizations of human gelatinase (type IV collagenase, MMP-9) and TIMP (tissue inhibitor of metalloproteinases) in normal epidermis and some epidermal tumors. Arch Dermatol Res 1996; 288: 239-244.
22. Kobayashi T, Shinkai H. Leptomycin B reduces matrix metalloproteinase-9 expression and suppresses cutaneous inflammation. J Invest Dermatol 2005; 124: 331-337.
23. Chan VT, Zhang DN, Nagarayapu U, et al. Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: expression and morphogenetic correlation. J Invest Dermatol 1998; 111: 1153-1159.
24. Nguyen M, Arkell J, Jackson CJ. Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles. J Biol Chem 1998; 273: 5400-5404.